Product Information
DILTIAZEM 30 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.0508 per EA under NDC 50228048105. Its NADAC has been published 172 times since Mar 15, 2023.
Strength
30 mg/1
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228048105
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216521On Market Since
9/26/2022
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 30 MG TABLET has been published 172 times since Mar 15, 2023, and over the history we have for it it has declined 44.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0508 per EA |
|---|---|
| All-time high | $0.0955 (Apr 10, 2024) |
| All-time low | $0.0505 (Jul 17, 2024) |
| 52-week high | $0.0581 |
| 52-week low | $0.0508 |
| Median price | $0.0673 |
| Average price | $0.0692 |
| Largest weekly change | +56.6% (Aug 21, 2024) |
| Weeks tracked | 172 |
| Tracking since | Mar 15, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DILTIAZEM 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 30 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.0508 per EA (NDC 50228048105), effective Jun 24, 2026.
How has the price of DILTIAZEM 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 30 MG TABLET has declined 44.7%. It has been tracked across 172 weekly CMS publications since Mar 15, 2023.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 30 MG TABLET?
Since Mar 15, 2023, the NADAC for DILTIAZEM 30 MG TABLET has ranged from a low of $0.0505 (Jul 17, 2024) to a high of $0.0955 (Apr 10, 2024), with a median of $0.0673 per EA.
Are there cheaper alternatives to DILTIAZEM 30 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DILTIAZEM 30 MG TABLET, but none are currently priced below it.
Who manufactures DILTIAZEM 30 MG TABLET?
DILTIAZEM 30 MG TABLET (NDC 50228048105) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification